StonvexLoading…
StonvexStonvexStonvexCore line items from AVY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.86B | $8.76B | $8.36B | $9.04B |
Operating Income | $925.10M | $953.50M | $694.70M | $999.30M |
Net Income | $688.00M | $704.90M | $503.00M | $757.10M |
EPS (Diluted) | $8.79 | $8.73 | $6.20 | $9.21 |
Total Assets | $8.80B | $8.40B | $8.21B | $7.95B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $202.80M | $329.10M | $215.00M | $167.20M |
Free Cash Flow OCF − CapEx | $712.40M | $730.00M | $560.70M | $682.90M |
Shares Outstanding | 76.88M | 79.80M | 80.50M | 80.81M |